Source: Annual Congress 2011 - What is new in tuberculosis immunodiagnosis?
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. G. Aabye, M. Ruhwald, G. PrayGod, D. Faurholt-Jepsen, K. Jeremiah, M. Faurholt-Jepsen, N. Range, H. Friis, J. Changalucha, A. B. Andersen, P. Ravn (Hvidovre, Frederiksberg, Copenhagen, Herlev, Denmark; Mwanza, Dar es Salaam, Tanzania, United Republic Of). Smoking is a strong independent risk factor for indeterminate and false negative IGRA results. Eur Respir J 2011; 38: Suppl. 55, 1898

Member's Comments

No comment yet.

Related content which might interest you: Unfavorable factors associated with false negative results of interferon-gamma release assay for tuberculosis Source: Annual Congress 2011 - Risk assessment for tuberculosis Year: 2011 Risk for progression to tuberculosis among arriving immigrants with a positive IGRA Source: Annual Congress 2011 - What is new in tuberculosis immunodiagnosis? Year: 2011 Negative predictive value of TST and IGRA in anti-TNF treated patients Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts Year: 2011 IGRA and TST predictive value in immunocompetent close contacts Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017 Year: 2017 Secondary TB risk in contacts over 35 years with IGRA positive latent tuberculosis Source: Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role? Year: 2010 Negative predictive value of TST and IGRA in anti-TNF treated patients}, Source: Eur Respir J 2012; 40: 790-791 Year: 2012 Predictive value for progression to tuberculosis by IGRA and TST in immigrant contacts Source: Eur Respir J 2010; 35: 1346-1353 Year: 2010 Predictive value of a whole-blood IGRA for the development of active TB disease Source: Annual Congress 2008 - Interferon-gamma methods for the diagnosis of tuberculosis infection and disease Year: 2008 The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection Source: International Congress 2016 – Latent tuberculosis infection Year: 2016 How do we handle nodules to minimise the false positive rate? Source: International Congress 2019 – NELSON: the Trafalgar of lung cancer screening? Year: 2019 Bronchiectasis and false positive cases in a lung cancer screening program Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020 Is it smoking a risk factor in tuberculosis? Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease Year: 2008 Smoking is a risk factor for TB infection, but is it an additional mortality risk? Source: Annual Congress 2011 - Management of tuberculosis Year: 2011 Risk of TB infection and smoking: IFN-gamma concentration increases with the cigarettes’ number in smokers Source: Annual Congress 2013 –Tuberculosis diagnosis Year: 2013 Can we predict who will develop TB among those with a positive interferon-? release assay (IGRA)? Source: International Congress 2018 – Important changes in the management of tuberculosis Year: 2018 False positive chlamydia pneumonia IgM assay induced by rheumatoid factor Source: Eur Respir J 2006; 28: Suppl. 50, 3s Year: 2006 Variables responsible for tuberculin positivity of household contacts of sputum positive TB cases Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond Year: 2011 TB failures, risk factors and therapeutical results Source: Eur Respir J 2003; 22: Suppl. 45, 523s Year: 2003